Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Files An 8-K Regulation FD Disclosure
Item 7.01
| Regulation FD Disclosure |
On June 20, 2017, Ekso Bionics Holdings, Inc. (the Company)
issued a letter to its shareholders. A copy of the Companys
letter to shareholders is attached hereto as Exhibit 99.1.
The information in this Item 7.01, including the exhibit attached
hereto, is furnished to Item 7.01 and shall not be deemed filed
for any other purpose, including for the purposes of Section 18
of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that Section. The information in
this Item 7.01 shall not be deemed incorporated by reference into
any filing under the Securities Act of 1933 or the Exchange Act
regardless of any general incorporation language in such filing
unless specifically provided otherwise.
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
| Exhibit | Description | |
| 99.1 | Letter to Shareholders dated June 20, 2017 |
EKSO BIONICS HOLDINGS, INC. ExhibitEX-99.1 2 v469372_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Shareholder Letter 2017 To our Shareholders: As we gather for our annual shareholder meeting,…To view the full exhibit click here
